Ventana Biotech, Inc.
VNTA · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $6 | $0 | $6 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $6 | $0 | $6 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0% | 0% | -95.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 0% | 0% | 0% | 0% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -104.4% | -199.6% | -445.6% | 53.9% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -104.4% | -199.6% | -554.6% | 53.9% |
| EPS Diluted | 0 | 0 | -0 | 0 |
| % Growth | – | 100% | -150% | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |